BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 6839760)

  • 1. Oral contraceptive steroids do not promote the development or growth of prolactinomas.
    Hulting AL; Werner S; Hagenfeldt K
    Contraception; 1983 Jan; 27(1):69-73. PubMed ID: 6839760
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral contraceptive exposure of amenorrheic women with and without prolactinomas.
    Jones JR; Kemmann E; Norwood PK
    Int J Gynaecol Obstet; 1981 Oct; 19(5):381-7. PubMed ID: 6120108
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral contraceptives and prolactinomas: a case-control study.
    Maheux R; Jenicek M; Cleroux R; Beauregard H; De Muylder X; Gratton NM; Van Campenhout J
    Am J Obstet Gynecol; 1982 May; 143(2):134-8. PubMed ID: 7081323
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prolactin-secreting pituitary adenoma: occurrence following prenatal exposure to diethylstilbestrol.
    Cunningham JR; Gidwani GP; Gupta MS; Duchesneau PM; Schumacher OP
    Cleve Clin Q; 1982; 49(4):249-54. PubMed ID: 7168914
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pituitary prolactinoma and estrogen contraceptives.
    Vaisrub S
    JAMA; 1979 Jul; 242(2):177-8. PubMed ID: 12309457
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of contraceptive steroids on hypothalamic-pituitary function.
    Mishell DR; Kletzky OA; Brenner PF; Roy S; Nicoloff J
    Am J Obstet Gynecol; 1977 May; 128(1):60-74. PubMed ID: 403765
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Oral contraceptives and prolactin-producing hypophyseal tumors].
    Lamberts SW
    Ned Tijdschr Geneeskd; 1980 Jan; 124(4):111-3. PubMed ID: 7374834
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral contraceptive history as a risk indicator in patients with pituitary tumors with hyperprolactinemia: a case comparison study of twenty patients.
    Teperman L; Futterweit W; Zappulla R; Malis LI
    Neurosurgery; 1980 Dec; 7(6):571-3. PubMed ID: 7193811
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The relation between oral contraceptive use and subsequent development of hyperprolactinemia.
    Badawy SZ; Rebscher F; Kohn L; Wolfe H; Oates RP; Moses A
    Fertil Steril; 1981 Oct; 36(4):464-7. PubMed ID: 7286268
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Galactorrhea in oral contraceptive users.
    Holtz G
    J Reprod Med; 1982 Apr; 27(4):210-2. PubMed ID: 7201522
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Secondary amenorrhoea and oral contraceptives.
    Ingerslev M; Jeppesen T; Ramsing EM
    Acta Obstet Gynecol Scand; 1976; 55(3):233-8. PubMed ID: 945653
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of combined oral contraceptive steroids on pituitary-ovarian function during the menstrual cycle of lactating women.
    Ryu K; Yu HK; Kwak HM; Hong SS
    Contraception; 1983 Mar; 27(3):299-310. PubMed ID: 6406140
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drugs that affect the breast and lactation.
    Dickey RP; Stone SC
    Clin Obstet Gynecol; 1975 Jun; 18(2):95-111. PubMed ID: 1095275
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pituitary and ovarian function in women receiving hormonal contraception.
    Cohen BL; Katz M
    Contraception; 1979 Nov; 20(5):475-87. PubMed ID: 393456
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Control of fertility with oral medication.
    Diddle AW; Watts GF; Gardner WH; Williamson PJ
    West J Surg Obstet Gynecol; 1964; 72():222-9. PubMed ID: 12305556
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The significance of galactorrhea in patients with normal menses, oligomenorrhea, and secondary amenorrhea.
    Davajan V; Kletzky O; March CM; Roy S; Mishell DR
    Am J Obstet Gynecol; 1978 Apr; 130(8):894-904. PubMed ID: 565142
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sex hormone profiles in oligomenorrheic adolescent girls and the effect of oral contraceptives.
    Siegberg R; Nilsson CG; Stenman UH; Widholm O
    Fertil Steril; 1984 Jun; 41(6):888-93. PubMed ID: 6233177
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Two-year treatment with oral contraceptives in hyperprolactinemic patients.
    Testa G; Vegetti W; Motta T; Alagna F; Bianchedi D; Carlucci C; Bianchi M; Parazzini F; Crosignani PG
    Contraception; 1998 Aug; 58(2):69-73. PubMed ID: 9773260
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral contraceptive agents do not affect serum prolactin in normal women.
    Davis JR; Selby C; Jeffcoate WJ
    Clin Endocrinol (Oxf); 1984 Apr; 20(4):427-34. PubMed ID: 6609028
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pituitary adenoma and oral contraceptives: a case-control study.
    Coulam CB; Annegers JF; Abboud CF; Laws ER; Kurland LT
    Fertil Steril; 1979 Jan; 31(1):25-8. PubMed ID: 369889
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.